Description
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia(ASPEN-1)
Please contact simr@sutterhealth.org about Study ASPEN-1 CD
Location: SIMR (Sacramento/Valley Area)
View study details on ClinicalTrials.gov
Principal Investigator
Recruitment Status
Active, Recruiting
Start Date
February 01, 2019